Effectiveness of Bupivacaine After Laparoscopic Cholecystectomy
NCT ID: NCT00599144
Last Updated: 2008-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2007-01-31
2008-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lidocaine and Analgesia After Laparoscopic Cholecystectomy
NCT03620591
COMPARISON OF INTRAOPERATIVE LOCAL ANESTHETIC APPLICATIONS IN POSTOPERATIVE PAIN MANAGEMENT IN LAPAROSCOPIC CHOLECYSTECTOMY PATIENTS
NCT03790007
Laparoscopic-Assisted Transversus Abdominus Plane Block Versus Intraperitoneal Irrigation of Local Anesthetic for Patients Undergoing Laparoscopic Cholecystectomy
NCT06714279
Postoperative Pain After Instillation Of Bupivacaine During Laparoscopic Cholecystectomy
NCT07098429
Comparison of Oblique Subcostal, Posterior or Dual Transversus Abdominis Plane Block in Laparoscopic Cholecystectomy
NCT04693156
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Group1: a bupivacaine 0,5% (2mg/kg) soaked-tabotamp is placed in gallbladder bed after remove of gallbladder
videolaparocholecystectomy
Group1: a bupivacaine 0,5% (2mg/kg) soaked-tabotamp is placed in gallbladder bed after remove of gallbladder
videolaparocholecystectomy
Group2: bupivacaine 0,5%(2mg/kg)is infiltrated in trocar incision after their closure.
2
Group2: bupivacaine 0,5%(2mg/kg)is infiltrated in trocar incision after their closure.
videolaparocholecystectomy
Group2: bupivacaine 0,5%(2mg/kg)is infiltrated in trocar incision after their closure.
3
Group3: control group without any local anesthetic use.
videolaparocholecystectomy
Group3: control group without any local anesthetic use.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
videolaparocholecystectomy
Group1: a bupivacaine 0,5% (2mg/kg) soaked-tabotamp is placed in gallbladder bed after remove of gallbladder
videolaparocholecystectomy
Group2: bupivacaine 0,5%(2mg/kg)is infiltrated in trocar incision after their closure.
videolaparocholecystectomy
Group3: control group without any local anesthetic use.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gallbladder adenomatous polyposis and cholelithiasis with no byochemical, clinical and instrumental evidence of acute cholecystitis at the moment of surgery.
Exclusion Criteria
* Pregnancy
* Previous major surgery of the supramesocholic compartment
* Acute cholecystitis
* Choledocolitiasis
* Acute pancreatitis at the moment of surgery
* Laparotomic conversion during surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Santa Maria alla Gruccia Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Asl 8 santa maria alla gruccia hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marco Scatizzi, MD
Role: PRINCIPAL_INVESTIGATOR
Ospedale Santa maria alla gruccia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ospedale santa maria alla gruccia
Montevarchi, Ar, Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Verma GR, Lyngdoh TS, Kaman L, Bala I. Placement of 0.5% bupivacaine-soaked Surgicel in the gallbladder bed is effective for pain after laparoscopic cholecystectomy. Surg Endosc. 2006 Oct;20(10):1560-4. doi: 10.1007/s00464-005-0284-5. Epub 2006 Aug 1.
Feroci F, Kroning KC, Moraldi L, Borrelli A, Ottaviano A, De Prizio M, Scatizzi M. [A new effective method to reduce pain after laparoscopic cholecystectomy]. G Chir. 2010 Oct;31(10):423-8. Italian.
Feroci F, Kroning KC, Scatizzi M. Effectiveness for pain after laparoscopic cholecystectomy of 0.5% bupivacaine-soaked Tabotamp placed in the gallbladder bed: a prospective, randomized, clinical trial. Surg Endosc. 2009 Oct;23(10):2214-20. doi: 10.1007/s00464-008-0301-6. Epub 2009 Jan 28.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
usl8
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.